Navigation Links
FasterCures Spotlights Addario Lung Cancer Medical Institute's Innovative Research Programs
Date:2/21/2012

SAN FRANCISCO, Feb. 21, 2012  /PRNewswire-USNewswire/ -- The Addario Lung Cancer Medical Institute's research portfolio is the featured innovator in FasterCures online platform for venture philanthropy in medical research. The innovator profile features a Q&A with Steven Young, president and COO of ALCMI, sister foundation of the Bonnie J. Addario Lung Cancer Foundation (BJALCF).

(Logo: http://photos.prnewswire.com/prnh/20120221/DC56587LOGO)

FasterCures, a nonprofit focused on accelerating the process of turning a scientific discovery into a viable therapy developed this resource to allow real-time sharing of innovative approaches to disease research. Called TRAIN (The Research Acceleration and Innovation Network) Central Station, it features best practices, leadership insights, tools and resources for the medical research foundation community.  ALCMI's innovator spotlight is the fifth of the series.

"ALCMI has made remarkable progress by applying innovative approaches to the conduct of research – from the shared infrastructure that links researchers to the way it effectively collects biological samples from patients. Approaches that are critical in bringing us closer to giving patients with lung cancer effective therapeutic options," said Margaret Anderson, executive director of FasterCures. "Amplifying lessons learned, sharing ideas as they happen, and facilitating an open exchange of strategies and approaches are the hallmarks of FasterCures' TRAIN program."

"To be recognized by FasterCures and TRAIN is an honor and a gift to all lung cancer patients," says Bonnie J. Addario, lung cancer survivor and founder of BJALCF and ALCMI.  "I am thrilled to be held accountable and to be on the same TRAIN team with collaborative giants like the Cystic Fibrosis Foundation, the International AIDS Vaccine Initiative, the Leukemia & Lymphoma Society, the Michael J. Fox Foundation for Parkinson's Research, Livestrong, and Susan G. Komen for the Cure, and others. Most important, I am happy that lung cancer research is at the TRAIN station and moving forward every day with an aggressive schedule to get the right therapies to the right patients at the right time. We're in a hurry."

Interview Excerpt:
Q: What prompted the creation of the institute?
A: In late 2007, the Bonnie J. Addario Lung Cancer Foundation invited leading physicians, clinicians, scientists, researchers, representatives from pharmaceutical and biotech companies, venture capitalists, international investors, and lung cancer survivors to convene at a Summit. They were invited for one purpose—to answer the following question: "If money for research and development was not a barrier and a true collaboration could be achieved, what would you do to improve lung cancer patient survival in the least amount of time and how much would it cost?" The unanimous answer: "We need a national lung cancer institute—an honest third-party broker—with a virtual specimen repository, connecting existing biobanks and researchers worldwide through a unique real-time IT platform and better means of collaboration." In response, the Addario Lung Cancer Medical Institute (ALCMI, voiced as "Alchemy") was founded in 2008 by lung cancer survivor Bonnie J. Addario and supporters to positively impact on lung cancer patient survival.

ALCMI is a contractual consortium of academic and community-based researchers structured to directly advance the understanding of disease biology and accelerate the development of significantly more effective treatment options. ALCMI links researchers via shared infrastructures and prioritized research programs including standardized biorepositories, data systems, contracts, study protocols, and, as significantly, through ongoing collaboration discussions among the scientists.

To read the entire Q&A interview, visit http://www.fastercures.org/train/CCC/spot.html.

For more information, or to learn more about how you can participate in eradicating lung cancer in our lifetime, please visit www.alcmi.net and/or www.lungcancerfoundation.org. To arrange interviews with Bonnie J. Addario and/or Steven Young, contact Sheila Von Driska at 415.357.1278 or sheila@lungcancerfoundation.org.

About the Bonnie J. Addario Lung Cancer Foundation
BJALCF is one of the largest philanthropies (patient-founded, patient-focused, patient-driven) devoted exclusively to eradicating lung cancer through research, early detection, education, and treatment. The Foundation works with a diverse group of physicians, organizations, industry partners, individuals, survivors, and their families to identify solutions and make timely and meaningful change. BJALCF was established in 2006 as a 501(c)(3) non-profit organization and has raised over nine million dollars for lung cancer research.

About the Addario Lung Cancer Medical Institute (ALCMI)
ALCMI was established in 2008 as a 501(c) (3) non-profit organization with the ultimate goal of significantly impacting survival by directly catalyzing and accelerating discovery of new and more effective treatment options for all lung cancer patients.  Presently, ALCMI has 13 academic and community medical centers in the United States and Europe closely collaborating on cutting edge research initiatives.


'/>"/>
SOURCE Addario Lung Cancer Medical Institute
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. FasterCures Rewards Two InnoCentive Solvers for Innovative Ideas to Accelerate Medical Research
2. BioSpace Spotlights Leading Life Science Community
3. BioSpace Spotlights Northwests Life Science Community
4. BioSpace Spotlights Southern Californias Life Science Community
5. BioSpace Spotlights Northern Californias Life Science Community
6. BioSpace Spotlights the Growing Midwest Life Science Community
7. Nucletron Spotlights Innovations During ESTRO29
8. Nanosurgery and the fight against cancer: Major breakthrough at Polytechnique Montral
9. Accelerate Brain Cancer Cure and Exosome Diagnostics Collaborate to Advance Clinical Studies of Exosome Biofluid Molecular Diagnostics Technology in Brain Cancer
10. Chinese Scientists Zhen-Yi Wang and Zhu Chen Awarded 7th Annual Szent-Gyorgyi Prize for Progress in Cancer Research
11. HPV Testing for Cervical Cancer Risk Patients set to Increase
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... 2016 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... the results of its 2016 Annual General Meeting, which was ... China . At the Annual ... of KPMG Huazhen LLP as the independent auditors of the ...
(Date:12/8/2016)... ... December 08, 2016 , ... Lajollacooks4u, San Diego’s premier team building ... team building events, new program offerings and company expansion. , This is ... to include groups of over 30 people. Ever since, Lajollacooks4u has seen significant demand ...
(Date:12/8/2016)... , Dec. 8, 2016  Renova™ Therapeutics, ... congestive heart failure and type 2 diabetes, announced ... a novel adeno-associated virus (AAV) vector developed in ... M.D., Ph.D., at Stanford University. The company plans ... paracrine gene therapy product pipeline. ...
(Date:12/8/2016)... OXFORD, England , December 8, 2016 ... Company, has expanded its customisable SureSeq™ NGS panel range with ... - allowing fast and cost-effective study of variants in familial ... copy number variation (CNV) detection on a single small panel ... and hotspot content. This includes all exons for LDLR ...
Breaking Biology Technology:
(Date:11/30/2016)... 2016  higi SH llc (higi) announced today ... national brands, industry thought-leaders and celebrity influencers looking ... for taking steps to live healthier, more active ... higi has built the largest self-screening health station ... people who have conducted over 185 million biometric ...
(Date:11/24/2016)... , Nov. 23, 2016 Cercacor today introduced ... and their trainers non-invasively measure hemoglobin, Oxygen ... Rate, and Respiration Rate in approximately 30 seconds. Smaller ... easy and immediate access to key data about their ... a training regimen. Hemoglobin carries oxygen ...
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
Breaking Biology News(10 mins):